E

ETON

ETON

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
8%Bearish
Buy/Sell Ratio0% buys
BearishBullish
ETON Live QuoteReal-time
$60.85
+$10.83(+21.65%)1M
Day Range$59.18 – $61.65
Open$61.00
Previous Close$61.36
Volume529.6K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$1.77B
P/E Ratio (TTM)39.8
Forward P/E20.2
EPS (TTM)$1.54
Price to Book20.6
Dividend Yield0.65%
Beta (Volatility)0.83
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
52-Week RangeCurrent: $60.85 (83%)
Low: $14.27High: $70.64
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$80.75-46.2% upside

Insider Buys

1

$125K

Insider Sales

12

$35.29M

Total Volume

$35.42M

13 transactions

Net Activity

$35.17M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
15CONFIDENCE

Sentiment Rating

Heavy Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
B
1

Brynjelsen Sean

Pres, CEO

0 buys3 sells

$13.51M total

O
2

Opaleye Management Inc.

10%

1 buys2 sells

$5.96M total

K
3

Krempa David

Chief Business Officer

0 buys3 sells

$5.36M total

C
4

Casamento Charles J

Dir

0 buys1 sells

$5.35M total

M
5

Maier Paul V

Dir

0 buys1 sells

$2.95M total

Trading History
ETON insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 10, 2026

1 weeks ago

Casamento Charles J

Dir

Director
Sell80.6K$66.35$5.35M

Aug 28, 2026

2 months ago

Maier Paul V

Dir

Director
Sell50.0K$59.07$2.95M

Aug 24, 2026

2 months ago

Krempa David

Chief Business Officer

C-Level
Sell25.0K$65.07$1.63M

Aug 19, 2026

3 months ago

Brynjelsen Sean

Pres, CEO

CEO
Sell100.0K$60.88$6.09M

Jul 14, 2026

4 months ago

Opaleye Management Inc.

10%

10% Owner
Sell28.3K$37.54$1.06M

Jul 2, 2026

4 months ago

Opaleye Management Inc.

10%

10% Owner
Sell126.7K$37.64$4.77M

Jun 17, 2026

5 months ago

Adams Jennifer McKie

Dir

Director
Sell50.0K$32.48$1.62M

May 28, 2026

5 months ago

Brynjelsen Sean

Pres, CEO

CEO
Sell120.0K$31.88$3.83M

May 22, 2026

6 months ago

Krempa David

Chief Business Officer

C-Level
Sell100.0K$32.30$3.23M

Aug 19, 2025

15 months ago

Gruber James R.

CFO

CFO
Sell41.7K$16.15$674K

Jun 12, 2025

17 months ago

Krempa David

Chief Business Officer

C-Level
Sell34.0K$14.83$504K

Jun 10, 2025

17 months ago

Opaleye Management Inc.

10%

10% Owner
Buy7.9K$15.82$125K

Jun 3, 2025

17 months ago

Brynjelsen Sean

Pres, CEO, 10%

CEO
Sell210.0K$17.11$3.59M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
ETON Buy Conviction0%
Industry Rank#183 of 569
Volume Contribution0.2%
Total Industry Activity$16.51B

ETON has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. ETON ranks #183 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for ETON

Over the last 90 days, corporate insiders at ETON (ETON) engaged in a total of 13 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 12 were sales. The total volume of insider trading reached $35.42M.

The net insider activity for ETON shows a net selling bias of $35.17M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Brynjelsen Sean (Pres, CEO), who traded 100.0K shares valued at $6.09M on Aug 19, 2026.

Live Market News & Developments
Aggregated real-time headlines for ETON (ETON)
6 updates

This Analyst Believes Eton Pharma’s Raised Guidance Is ‘Conservative’ – ETON Stock Heads For Best Ever Day

Yahoo Finance98d ago

Why Eton Pharmaceuticals Is Top of the Class Today

The Motley Fool98d ago

Eton Pharma jumps after Q3 beat and guidance hike

Seeking Alpha14d ago

Why Top 3% Biotech Stock, Eton, Just Catapulted To A Record High

Investor's Business Daily98d ago

ETON - Eton Pharmaceuticals Inc Stock Price and Quote

Finviz177d ago

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Stock Now Rated "Moderate Buy" by Sell-Side Analysts

MarketBeat3d ago

FAQs About ETON Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for ETON.

Based on SEC Form 4 disclosures, the Insider Confidence Score for ETON is currently 15/100, which reflects a heavy distribution bias. This calculation accounts for a total of 1 purchases and 12 sales by company executives over the last 90 days.

The CEO Conviction Index for ETON is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.